ZD 2486

• Description:

  ZD 2486 is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist. ZD 2486 inhibits platelet aggregation by blocking the binding of fibrinogen to the GP IIb/IIIa receptor on platelets. ZD 2486 can be used for the study of conditions related to unwanted platelet aggregation, such as acute coronary syndrome, unstable angina pectoris, acute myocardial infarction, and complications from cardiovascular interventional procedures[1]

• UNSPSC:

  12352005

• Target:

  Integrin

• Related Pathways:

  Cytoskeleton

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O=C(O)C[C@@H](C)COC1=CC=C(C=C1)N2CCN(C3=CC=NC=C3)CC2

• Molecular Formula:

  C20H25N3O3

• Molecular Weight:

  355.43

• References & Citations:

  [1]Porter, S. R., et al. Combination Therapy for Inhibition of Platelet Aggregation. WO 2005/087266 A1. World Intellectual Property Organization (WIPO) . 22 September 2005

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  185836-64-0